IRON
Disc Medicine Inc.
64.50$
+1.4%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -2.3% | -3.8% | +44.1% | -3.0% | +0.3% | +42.8% | -6.2% | -5.2% | +28.0% | -7.0% | -2.0% | |
| – | -2.3% | -3.8% | +44.4% | -3.0% | +0.1% | +42.9% | -6.2% | -5.2% | +28.2% | -7.0% | -2.0% | |
| – | -2.7% | -4.9% | -18.1% | -31.4% | -0.1% | -36.3% | +3.8% | +10.5% | -35.2% | -2.4% | +11.0% | |
| – | -2.7% | -4.9% | +46.2% | -2.7% | +0.5% | +41.8% | -6.4% | -5.2% | +28.5% | -7.7% | -1.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +30.5% | -29.6% | +32.8% | +27.1% | +95.6% | -8.1% | +4.1% | +12.1% | +17.5% | -7.9% | +47.1% | |
| – | +48.7% | -30.7% | +36.7% | +25.4% | -8.5% | -19.6% | +10.0% | +29.8% | +37.0% | -15.0% | -2.5% | |
| – | +88.4% | +15.3% | -1.0% | -90.0% | +71.1% | +268.5% | +31.9% | +3.8% | -6.9% | -31.4% | -24.8% | |
| – | +48.6% | -58.3% | -9.9% | -25.2% | +123.7% | -15.7% | -5.3% | +14.5% | +24.1% | +30.4% | -41.8% | |
| – | – | – | – | – | – | +0.7% | +0.7% | +0.7% | +0.7% | +0.7% | +102.1% | |
| – | -3.9% | -2.0% | +44.6% | -4.3% | -5.2% | +48.9% | -7.0% | -6.6% | +29.0% | -6.9% | -6.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.1% | +5.3% | +3.4% | +16.7% | +0.0% | +11.3% | +5.1% | +0.4% | +0.3% | +9.1% | +0.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.